Scientific Sessions 2024  /  TAVR Potpourri  /  Pulmonary Artery Enlargement Predicts Mortality in Patients with Severe Aortic Stenosis after Transcatheter Aortic Valve Replacement.
Logo

American Heart Association

  9
  0

Final ID: Sa4079

Pulmonary Artery Enlargement Predicts Mortality in Patients with Severe Aortic Stenosis after Transcatheter Aortic Valve Replacement.

Abstract Body (Do not enter title and authors here): Background: Pulmonary hypertension is associated with extensive remodeling of the pulmonary tree, with key finding the enlargement of the pulmonary artery (PA). Although the independent predictive value of the pulmonary hypertension in patients undergoing transcatheter aortic valve replacement for severe aortic stenosis has been clearly demonstrated, data about the potential predictive value of the pre-interventional PA enlargement on mortality are scarce.

Research questions: The aim of the present study was to assess the prognostic significance of the pre-interventional PA enlargement, assessed by cardiac CT scan, in patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.

Methods: We conducted a retrospective study and recruited 337 patients with aortic stenosis, who underwent a right heart catheterization and a cardiac CT scan before the transcatheter aortic valve replacement. The cohort was divided in two groups according to the presence of an enlarged PA (PAe), (main PA axial diameter ≥ 29 mm for males and ≥ 27 mm for females, n=192, mean age 83±6 years, 41% males) or not (PAn), ( n=145, mean age 84±6 years, 46% males). The primary endpoint was all-cause mortality at 1 year.

Results: Globally, a strong correlation between invasive mean PA pressure and main PA axial diameter was noted (Pearson r=0.393, p<0 .001). Compared to the PAn group, patients with enlarged PA exhibited higher 1 year mortality rates (hazard ratio 2.51, 95% CI: 1.1-6.04, p=0.027). The prognostic significance was even stronger after indexing the PA to the ascending aorta diameter (hazard ratio 3.82, 95% CI: 1.86-7.87, p<0.001, figure 1).

Conclusions: Pre interventional PA enlargement, is strongly associated with 1-year all-cause mortality in patients undergoing transcatheter aortic valve. This may pave the way for a more precise non-invasive risk stratification in patients with severe aortic stenosis.
  • Adamopoulos, Dionysios  ( University hospital of Geneva , Geneva , Switzerland )
  • Noble, Stephane  ( University hospital of Geneva , Geneva , Switzerland )
  • Gkotsoulia, Christina  ( University hospital of Geneva , Geneva , Switzerland )
  • Muller, Hajo  ( University hospital of Geneva , Geneva , Switzerland )
  • Vallee, Jean-paul  ( University hospital of Geneva , Geneva , Switzerland )
  • Crowe, Lindsey  ( University hospital of Geneva , Geneva , Switzerland )
  • Deux, Jean-francois  ( University hospital of Geneva , Geneva , Switzerland )
  • Mauler-wittwer, Sarah  ( University hospital of Geneva , Geneva , Switzerland )
  • Lador, Frederic  ( University hospital of Geneva , Geneva , Switzerland )
  • Mach, Francois  ( University hospital of Geneva , Geneva , Switzerland )
    • Author Disclosures:
    Dionysios Adamopoulos: DO NOT have relevant financial relationships | Stephane Noble: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Speaker:Edwards Lifesciences:Past (completed) ; Consultant:Abbott vas:Active (exists now) ; Speaker:Gore medical:Past (completed) ; Speaker:Abiomed:Past (completed) | Christina Gkotsoulia: DO NOT have relevant financial relationships | Hajo Muller: No Answer | Jean-Paul Vallee: No Answer | Lindsey Crowe: DO NOT have relevant financial relationships | Jean-Francois Deux: No Answer | Sarah Mauler-Wittwer: No Answer | Frederic Lador: No Answer | Francois Mach: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

TAVR Potpourri

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts on this topic:
Biased Activation of RXFP1 signaling via ML290 Attenuates Experimental Pulmonary Hypertension

Sangam Shreya, Brackin Riley, Zeghibe Ana, Shin Elizabeth, Agoulnik Irina, Marugan Juan, Agoulnik Alexander, Rajagopal Sudarshan, Yu Paul, Triantafyllou Georgios, Pham Uyen, Troncone Luca, Yung Lai-ming, Chundi Anand, Darbha Srikrishna, Gipson Gregory, Rajesh Shreyas

Acoramidis Reduces All-Cause Mortality (ACM) and Cardiovascular-Related Hospitalization (CVH): Initial Outcomes From the ATTRibute-CM Open-Label Extension (OLE) Study

Judge Daniel, Masri Ahmad, Obici Laura, Poulsen Steen, Sarswat Nitasha, Shah Keyur, Soman Prem, Cao Xiaofan, Wang Kevin, Pecoraro Maria, Tamby Jean-francois, Gillmore Julian, Katz Leonid, Fox Jonathan, Maurer Mathew, Alexander Kevin, Ambardekar Amrut, Cappelli Francesco, Fontana Marianna, Garcia-pavia Pablo, Grogan Martha, Hanna Mazen

4119146_File000000.jpg
4119146_File000000.jpg
You have to be authorized to contact abstract author. Please, Login
Not Available